Bausch Health Companies Inc. - Multiplikator EV/Sales BHC

Logo perusahaan publik bauschhealth.com (BHC)

Bausch Health Companies (BHC) is betting on sales experts and strict cost control. The EV/Sales valuation multiple reflects the dynamics of this approach, where 2017.25 represents the current level of the metric. High barriers to entry driven by patents protect the business, while the strategy for debt restructuring and the spin-off of the ophthalmology sector is designed to stabilize the company's cash flows.

BHC Rasio nilai perusahaan marang pendapatan Bausch Health Companies (23.11.2025 - 20.11.2026)

Valeant Pharmaceuticals - rincian analitis lan metrik utama (BHC)

Pambiji fundamental:Bausch Health Companies BHC
Produk asil prodhuksi Bausch Health Companies Inc.

For Bausch Health Companies (BHC), burdened by debt and generic pressure, it is critical to track the real value of the business excluding leverage. By analyzing the EV/Sales valuation chart, an investor compares enterprise value with sales volume, which allows them to filter out speculative noise and determine whether the company's current market value is justified based on its fundamental ability to generate revenue.